Overview


Bioanalysis is an analytical branch of chemistry that analyzes biological samples to determine the size of DNA and other large molecules. In the healthcare industry, the terms analytical services and bioanalytical services are often used interchangeably. Bioanalytical services can be used to study toxicology, pharmacology, and bioequivalence, as well as pharmacokinetic or bioavailability studies on animals. All phases of drug development are covered by bioanalytical services, including discovery and clinical development. One difference between analytical and bioanalytical services is that bioanalytical is used to determine the amount of drug in a biological sample, while analytical services are used for qualitative parameters. These services can be performed using a variety of bioanalytical platforms, including LC/MS and gas chromatography.
In the coming years, there will be many growth opportunities for the bioanalytical market. The market for bioanalytical services is expected to grow due to the increasing incidence of infectious diseases. Many pharmaceutical companies now collaborate with research institutes to provide the necessary bioanalytical services. Pre-clinical and fluid testing, specimen or fluid testing, analysis of clinical samples, the investigation into infection by viruses in the body, and so on are all bioanalytical services. These services offer market participants significant growth opportunities in the wake of the global pandemic. The major role of bioanalytical services in COVID-19 vaccine programs and drug investigation was played by them. Despite the pandemic in the bioanalytical market, ongoing assays, vaccine testing solutions, and drug inspection procedures are creating revenue opportunities.
Bioanalytical services are in high demand in the pharmaceutical and biotechnology industries. Bioanalytical services are in high demand due to their higher cost and longer duration. This is why pharmaceutical and biotechnology companies have begun to outsource bioanalytical services. The rise in chronic diseases, and the consequent increase in economic costs, is causing a demand for personalized medicine and new drugs to be developed. This has resulted in a rise in investment by biopharmaceutical firms in R D, and drug development, and a higher demand for bioanalytical services in the global market. This, along with the increasing number of players in the global bioanalytical market that offer a diverse and complete portfolio of bioanalytical service offerings, has fueled the market's growth.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Bioanalytical Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Bioanalytical Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• ICON Plc
• Covance Inc
• Charles River Laboratories International
• Bio-Rad Laboratories
• Eurofins Scientific
• WuXi AppTec
• PPD Inc
• IQVIA
• Syneos Health
• Intertek Group Plc
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Test Type
• ADME (Absorption, Distribution, Metabolism, and Excretion)
• Pharmacokinetic
• Pharmacodynamic
• Bioavailability
• Bioequivalence
By Molecule Type
• Small Molecules
• Large Molecules
• Vaccines
By End User
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Oranisations
By Region
• North America
Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Bioanalytical Services Market By Test type, By Molecule Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Bioanalytical Services Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Bioanalytical Services Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Bioanalytical Services Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Bioanalytical Services Market, By Test type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. ADME (Absorption, Distribution, Metabolism, and Excretion)
        2. Pharmacokinetic
        3. Pharmacodynamic
        4. Bioavailability
        5. Bioequivalence
  • 8.   Bioanalytical Services Market, By Molecule Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Small Molecules
        2. Large Molecules
        3. Vaccines
  • 9.   Bioanalytical Services Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Contract Research Oranisations
  • 10.   North America Bioanalytical Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Bioanalytical Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Bioanalytical Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Bioanalytical Services Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. ICON Plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Covance Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Charles River Laboratories International
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bio-Rad Laboratories
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eurofins Scientific
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. WuXi AppTec
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. PPD Inc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. IQVIA
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Syneos Health
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Intertek Group Plc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients